Equipping NK Cells with CARs

    Cancer Discovery
    |September 8, 2017
    PubMed
    Summary

    Chimeric antigen receptor (CAR) natural killer (NK) cells offer a promising off-the-shelf therapy for blood cancers. A phase I/II trial is evaluating a CAR NK-cell therapy targeting CD19 in hematologic malignancies.